Anna Minarini
Anna Minarini
Professore di Chimica Farmaceutica, UniversitÓ di Bologna
Verified email at unibo.it
TitleCited byYear
Multi-target-directed ligands to combat neurodegenerative diseases
A Cavalli, ML Bolognesi, A Minarini, M Rosini, V Tumiatti, M Recanatini, ...
Journal of medicinal chemistry 51 (3), 347-372, 2008
8132008
Rational approach to discover multipotent anti-Alzheimer drugs
M Rosini, V Andrisano, M Bartolini, ML Bolognesi, P Hrelia, A Minarini, ...
Journal of medicinal chemistry 48 (2), 360-363, 2005
2332005
Inhibition of acetylcholinesterase, β-amyloid aggregation, and NMDA receptors in Alzheimer’s disease: a promising direction for the multi-target-directed ligands gold rush
M Rosini, E Simoni, M Bartolini, A Cavalli, L Ceccarini, N Pascu, ...
Journal of medicinal chemistry 51 (15), 4381-4384, 2008
1802008
Tacrine derivatives and Alzheimer's disease
V Tumiatti, A Minarini, ML Bolognesi, A Milelli, M Rosini, C Melchiorre
Current medicinal chemistry 17 (17), 1825-1838, 2010
1712010
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease
ML Bolognesi, R Banzi, M Bartolini, A Cavalli, A Tarozzi, V Andrisano, ...
Journal of medicinal chemistry 50 (20), 4882-4897, 2007
1272007
Alzheimer's disease: new approaches to drug discovery
ML Bolognesi, R Matera, A Minarini, M Rosini, C Melchiorre
Current opinion in chemical biology 13 (3), 303-308, 2009
1252009
Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots? Miniperspective
M Rosini, E Simoni, A Milelli, A Minarini, C Melchiorre
Journal of medicinal chemistry 57 (7), 2821-2831, 2013
1162013
Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues
ML Bolognesi, M Bartolini, A Cavalli, V Andrisano, M Rosini, A Minarini, ...
Journal of medicinal chemistry 47 (24), 5945-5952, 2004
1062004
Multifunctional tacrine derivatives in Alzheimer's disease
A Minarini, A Milelli, E Simoni, M Rosini, M Laura Bolognesi, C Marchetti, ...
Current topics in medicinal chemistry 13 (15), 1771-1786, 2013
722013
MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond
ML Bolognesi, M Rosini, V Andrisano, M Bartolini, A Minarini, V Tumiatti, ...
Current pharmaceutical design 15 (6), 601-613, 2009
692009
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment
A Minarini, A Milelli, V Tumiatti, M Rosini, E Simoni, ML Bolognesi, ...
Neuropharmacology, 2012
672012
Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity
ML Bolognesi, M Bartolini, A Tarozzi, F Morroni, F Lizzi, A Milelli, ...
Bioorganic & medicinal chemistry letters 21 (9), 2655-2658, 2011
672011
Multi-target design strategies in the context of Alzheimer’s disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces
M Rosini, E Simoni, A Minarini, C Melchiorre
Neurochemical research 39 (10), 1914-1923, 2014
642014
Structure− activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer
V Tumiatti, A Milelli, A Minarini, M Rosini, ML Bolognesi, M Micco, ...
Journal of medicinal chemistry 51 (22), 7308-7312, 2008
642008
From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease
ML Bolognesi, A Minarini, M Rosini, V Tumiatti, C Melchiorre
Mini reviews in medicinal chemistry 8 (10), 960-967, 2008
582008
Polyamines in drug discovery: from the universal template approach to the multitarget-directed ligand design strategy
C Melchiorre, ML Bolognesi, A Minarini, M Rosini, V Tumiatti
Journal of medicinal chemistry 53 (16), 5906-5914, 2010
572010
Polymethylene tetraamines as muscarinic receptor probes.
C Melchiorre, A Minarini, P Angeli, D Giardina, U Gulini, W Quaglia
Trends in pharmacological sciences 10 (Suppl.), 55-59, 1989
531989
Design, synthesis, and biological evaluation of substituted naphthalene imides and diimides as anticancer agent
V Tumiatti, A Milelli, A Minarini, M Micco, A Gasperi Campani, L Roncuzzi, ...
Journal of medicinal chemistry 52 (23), 7873-7877, 2009
502009
Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration.
ML Bolognesi, A Minarini, V Tumiatti, C Melchiorre
Mini reviews in medicinal chemistry 6 (11), 1269-1274, 2006
502006
Binding profile of the selective muscarinic receptor antagonist tripitramine
R Maggio, P Barbier, ML Bolognesi, A Minarini, D Tedeschi, C Melchiorre
European Journal of Pharmacology: Molecular Pharmacology 268 (3), 459-462, 1994
481994
The system can't perform the operation now. Try again later.
Articles 1–20